WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Brilacidin

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi.

    DOI: 10.1038/s41467-023-37573-y

    Source identity and connection checked by Codex (AI).

  2. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.

    DOI: 10.1002/jmv.27616

    Source identity and connection checked by Codex (AI).

  3. Brilacidin, a novel antifungal agent against Cryptococcus neoformans.

    DOI: 10.1128/mbio.01031-24

    Source identity and connection checked by Codex (AI).

  4. Busting Cryptococcus with brilacidin.

    DOI: 10.1038/s41579-024-01081-7

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Dos Reis TF
  • de Castro PA
  • Bastos RW
  • Pinzan CF
  • Souza PFN
  • Ackloo S
  • Hossain MA
  • Drewry DH
  • Alkhazraji S
  • Ibrahim AS
  • Jo H
  • Lightfoot JD
  • Adams EM
  • Fuller KK
  • deGrado WF
  • Goldman GH
  • Taglialegna A
  • Hu Y
  • DeGrado WF
  • Wang J
  • Diehl C
  • Delbaje E
  • García Carnero LC
  • Sánchez-León E
  • Bhalla K
  • Kronstad JW
  • Kim D-g
  • Doering TL
  • Mishra NN
  • Yoshimura M
  • Vega Isuhuaylas LA
  • Pham LTK
  • Yashiroda Y
  • Boone C